Logo

Phase Genomics

Phase Genomics Wins $5.5M in NIH, Gates Foundation Grants for Therapeutic Phage Discovery

The company will use its proximity-guided metagenomics platform to build an atlas of phage-bacteria interactions and identify phages that could be used therapeutically.

New Products Posted to GenomeWeb: Phase Genomics, Centogene, Biotium

Phase Genomics Wins $1.7M NIH Grant for Virus Discovery Platform Development

The platform, based on the firm's Hi-C technology, is designed to assembly viral genomes from metagenomic samples and associate them with their microbial hosts.

Qiagen, Phase Genomics Ink US Licensing Agreement for Hi-C Sequencing Technology

Qiagen can now sell Phase's proprietary proximity-ligation technology for chromatin conformational analysis research in the US.

NIH Awards Two SBIR Grants Totaling $3.9M to Phase Genomics

The Seattle-based firm has won two grants each worth $1.9 million to develop proximity ligation assays with applications in cytogenetics.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.